Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Apr 4;162(5):1516–1528.e1. doi: 10.1016/j.jtcvs.2020.02.137

Figure 1.

Figure 1.

ATAs recurrence-free survival by Kaplan-Meier estimation. The composite endpoint is estimated as the probability of being both alive and having not experienced any recurrence of ATAs. At each timepoint, this composite endpoint survival probability and the cumulative incidences for the competing risks of death and ATAs recurrence sum to one. Percentage of patients estimated to be alive and free of ATAs recurrence at each year can be found in Table 4.